BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11769528)

  • 1. [Membranous nephropathy associated with hepatitis C virus infection].
    Arakawa S; Kobayashi S; Fujomoto S; Shindo A; Fukushima T; Sasaki T; Kashihara N
    Nihon Naika Gakkai Zasshi; 2001 Nov; 90(11):2284-6. PubMed ID: 11769528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Membranous nephropathy and hepatitis C virus infection].
    Egea JJ; Rivera F; Arenas MD; Olivares J
    Nefrologia; 2001; 21(4):411-2. PubMed ID: 11816520
    [No Abstract]   [Full Text] [Related]  

  • 3. [Virus associated glomerulonephritis].
    Tillmann HL; Schwarz A
    Internist (Berl); 2003 Sep; 44(9):1098-106. PubMed ID: 14566463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appearance of nephrotic syndrome following interferon-alpha therapy in a patient with hepatitis B virus and hepatitis C virus coinfection.
    Endo M; Ohi H; Fujita T; Ohsawa I; Kanmatsuse K; Yamaguchi Y
    Am J Nephrol; 1998; 18(5):439-43. PubMed ID: 9730572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infection.
    Ji F; Li Z; Ge H; Deng H
    Intern Med; 2010; 49(22):2531-2. PubMed ID: 21088367
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hepatitis B virus-associated membranous glomerulonephritis with interferon alfa in a 7 year old boy].
    Steiss JO; Piske-Keyser K; Gröne HJ; Gortner L
    Klin Padiatr; 2000; 212(5):283-6. PubMed ID: 11048290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal.
    Fabrizi F; Pozzi C; Farina M; Dattolo P; Lunghi G; Badalamenti S; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1998 Aug; 13(8):1991-7. PubMed ID: 9719153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLA2R related primary membranous nephropathy in a hepatitis C positive patient.
    Ramachandran R; Yadav AK; Kumar V; Varma A; Taneja S; Nada R; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Mar; 23(3):288. PubMed ID: 29460999
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of hepatitis B virus-associated membranous nephropathy: lamivudine era versus post-lamivudine era.
    Moon JY; Lee SH
    Korean J Intern Med; 2012 Dec; 27(4):394-6. PubMed ID: 23269879
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral therapy for hepatitis C virus infection, cryoglobulinemic glomerulonephritis and low-grade malignant lymphoma: A challenge?
    Ennaifer R; Sabbah M; Hefaiedh R; Romdhane H; Cheikh M; Belhadj N
    Tunis Med; 2015 Mar; 93(3):203-4. PubMed ID: 26367421
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective characterization of the S open reading frame of HBV isolated from children with membranous nephropathy treated with interferon-alpha2b.
    Gous N; Bhimma R; Kew M; Kramvis A
    Antivir Ther; 2010; 15(1):61-9. PubMed ID: 20167992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed cryoglobulinaemia and hepatitis C virus infection.
    Grandinetti F; De Paola L; Prunesti P; Mazzitello G
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):579. PubMed ID: 9513839
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe acute cerebrovascular disease revealing hepatitis C virus infection: effectiveness of alpha-interferon.
    Marchioni E; Ceroni M; Erbetta A; Alfonsi E; Bottanelli M; Imbesi F; Ricevuti G
    J Neurol; 2002 Aug; 249(8):1111-3. PubMed ID: 12420713
    [No Abstract]   [Full Text] [Related]  

  • 14. Membranous nephropathy associated with chronic hepatitis B occurring in a short period after acute hepatitis B virus infection.
    Nakahara K; Takahashi H; Okuse C; Shigefuku R; Yamada N; Murao M; Matsunaga K; Koike J; Yotsuyanagi H; Suzuki M; Kimura K; Itoh F
    Intern Med; 2010; 49(5):383-8. PubMed ID: 20190469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy.
    Komatsuda A; Imai H; Wakui H; Hamai K; Ohtani H; Kodama T; Oyama Y; Miura AB; Nakamoto Y
    Intern Med; 1996 Jul; 35(7):529-33. PubMed ID: 8842757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
    Sabry AA; Sobh MA; Sheaashaa HA; Kudesia G; Wild G; Fox S; Wagner BE; Irving WL; Grabowska A; El-Nahas AM
    Nephrol Dial Transplant; 2002 Nov; 17(11):1924-30. PubMed ID: 12401848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
    PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy.
    Hu SL; Jaber BL
    Clin Nephrol; 2005 Jan; 63(1):41-5. PubMed ID: 15678695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between type II cryoglobulinemia and hepatitis C virus in a case treated with interferon-alpha.
    Fukumoto S; Ishimura E; Shoji S; Izumotani T; Kitahashi S; Kuroki T; Nishizawa Y; Morii H
    Nephron; 1996; 73(1):94-6. PubMed ID: 8742965
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete remission of hepatitis B virus-related membranous nephropathy after entecavir monotherapy.
    Yang YF; Xiong QF; Zhao W; Zhong YD
    Clin Res Hepatol Gastroenterol; 2012 Oct; 36(5):e89-92. PubMed ID: 22572521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.